You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.
Genome editing will likely first touch many people's lives through its use in agriculture, says the University of California, Berkeley's Jennifer Doudna at the Financial Times.
In Science this week: CRISPR-based approach for recording cellular events, and more.
In PNAS this week: method to predict cancer susceptibility, root microbiome, and more.
Researchers from the Doudna lab and the National Human Genome Research Institute held an 'Ask Me Anything' on Reddit last week.
The Broad Institute also announced announced a setback in proceedings over a CRISPR patent application filed in Europe.
The University of California, Berkeley, and chocolate-maker Mars are working together to tweak cacao plants using gene editing so the plants can handle climate change.
Gizmodo wonders whether CRISPR could present a treatment for amyotrophic lateral sclerosis.
In Science this week: genomic studies of how fungal pathogen overcomes resistant wheat plants, and more.
Graduate students and others object to the US House of Representatives tax bill treating tuition waivers as income.
23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.
The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.
The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.
In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.